CliffBio
small molecule

ZANTAC 150

RANITIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyGLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Drug detail

Brand nameZANTAC 150
Active ingredientRANITIDINE HYDROCHLORIDE
StrengthEQ 150MG BASE/PACKET
Dosage formGRANULE, EFFERVESCENT
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1994
Marketing statusDISCN

More from GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ZANTAC 150 patent cliff — loss of exclusivity — | CliffBio